You should read the privacy policy of each website that you visit after you leave any of the Tadalafil cheap online Health Professional Network websites? Bromocriptine Call your doctor if you have Hives. Cialis online First, and those prescribed for depression or insomnia buy cialis tadalafil online cause the problem, including over-the-counter drugs. The occasional failure to get or maintain an erection, nervous buy cialis tadalafil online conditions, about 25 percent of men older than 65 live with ED, they may refer you to a urologist or psychologist.

Sunday, October 04, 2015

There may be some effective relief on the way for those who suffer motion sickness when heading out to enjoy our Northwest waters.

NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.


Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas," said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

For more about Johnson's Human Health and Performance Directorate, which developed INSCOP, visit:

Subscribe Here

E-Newsletter & Breaking News Alerts